Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Brooks

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
MMWR. Morbidity and Mortality Weekly Report|December 7, 2023
Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Sarah Kidd, Thomas Clark, Janell Routh, et al.
MMWR. Morbidity and Mortality Weekly Report|April 25, 2024
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024Lakshmi Panagiotakopoulos, Monica Godfrey, Danielle L Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2023
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Jefferson M Jones, Katherine E Fleming-Dutra, Mila M Prill, et al.
MMWR. Morbidity and Mortality Weekly Report|September 19, 2024
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025Lakshmi Panagiotakopoulos, Danielle L Moulia, Monica Godfrey, et al.
MMWR. Morbidity and Mortality Weekly Report|August 29, 2025
Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025Danielle L Moulia, Ruth Link-Gelles, Helen Y Chu, et al.
MMWR. Morbidity and Mortality Weekly Report|October 12, 2023
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Katherine E Fleming-Dutra, Jefferson M Jones, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2022
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022Hannah G Rosenblum, Megan Wallace, Monica Godfrey, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021Kate R Woodworth, Danielle Moulia, Jennifer P Collins, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021Kathleen Dooling, Julia W Gargano, Danielle Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021Sarah Mbaeyi, Sara E Oliver, Jennifer P Collins, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
MMWR. Morbidity and Mortality Weekly Report|December 7, 2023
Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Sarah Kidd, Thomas Clark, Janell Routh, et al.
MMWR. Morbidity and Mortality Weekly Report|April 25, 2024
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024Lakshmi Panagiotakopoulos, Monica Godfrey, Danielle L Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|August 24, 2023
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Jefferson M Jones, Katherine E Fleming-Dutra, Mila M Prill, et al.
MMWR. Morbidity and Mortality Weekly Report|September 19, 2024
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025Lakshmi Panagiotakopoulos, Danielle L Moulia, Monica Godfrey, et al.
MMWR. Morbidity and Mortality Weekly Report|August 29, 2025
Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025Danielle L Moulia, Ruth Link-Gelles, Helen Y Chu, et al.
MMWR. Morbidity and Mortality Weekly Report|October 12, 2023
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Katherine E Fleming-Dutra, Jefferson M Jones, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2022
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022Hannah G Rosenblum, Megan Wallace, Monica Godfrey, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021Kate R Woodworth, Danielle Moulia, Jennifer P Collins, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021Kathleen Dooling, Julia W Gargano, Danielle Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021Sarah Mbaeyi, Sara E Oliver, Jennifer P Collins, et al.
Pageof 2